
News|Articles|February 13, 2019
Firdapse for LEMS in Adults
Author(s)Drew Boxler
Advertisement
Firdapse (amifampridine, Catalyst Pharmaceuticals)
Indications: treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults.
Dosage: 15 mg to 30 mg daily taken orally in divided doses (3 to 4 times daily); increased by 5mg daily every 3-4 days, not to exceed 80mg daily
Contraindications: History of seizures; hypersensitivity to amifampridine or another aminopyridine
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Long-Term Adverse Effects After COVID-19 Vaccination Vary by Brand
2
Meta-Analysis Identifies 5 Risk Factors for Post-COVID-19 Condition
3
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
4
Investigational Oral AD109 Reduces Sleep Apnea Severity by 44%
5







































